| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivors
|
Hjelle, Line V.
|
|
2016
|
34 |
11 |
p. 487.e13-487.e20
|
artikel
|
| 2 |
Cell-cycle markers do not improve discrimination of EORTC and CUETO risk models in predicting recurrence and progression of non–muscle-invasive high-grade bladder cancer
|
Passoni, Niccolo
|
|
2016
|
34 |
11 |
p. 485.e7-485.e14
|
artikel
|
| 3 |
Cell-free and circulating tumor cell–based biomarkers in men with metastatic prostate cancer: Tools for real-time precision medicine?
|
Miyamoto, David T.
|
|
2016
|
34 |
11 |
p. 490-501
|
artikel
|
| 4 |
Circulating biomarkers to guide systemic therapy for urothelial carcinoma
|
Abbosh, Philip H.
|
|
2016
|
34 |
11 |
p. 502-509
|
artikel
|
| 5 |
Commentary on “A large-scale analysis of genetic variants within putative miRNA binding sites in prostate cancer.” Stegeman S, Amankwah E, Klein K, O’Mara TA, Kim D, Lin HY, Permuth-Wey J, Sellers TA, Srinivasan S, Eeles R, Easton D, Kote-Jarai Z, Amin Al Olama A, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pharoah P, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Kaneva R, Teixeira MR, PRACTICAL Consortium, Australian Prostate Cancer BioResource, Spurdle AB, Clements JA, Park JY, Batra J, University of Washington—Urology, Seattle, WA. Cancer Discov 2015; 5(4):368-79.
|
Lin, Daniel
|
|
2016
|
34 |
11 |
p. 522-523
|
artikel
|
| 6 |
Commentary on “AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.” Antonarakis ES, Lu C, Wang H, Luber B, Nakazawa M, Roeser JC, Chen Y, Mohammad TA, Chen Y, Fedor HL, Lotan TL, Zheng Q, De Marzo AM, Isaacs JT, Isaacs WB, Nadal R, Paller CJ, Denmeade SR, Carducci MA, Eisenberger MA, Luo J, Division of Urologic Oncology, Department of Urology, University of Michigan, MI. N Engl J Med 2014; 371(11):1028-38.
|
Palapattu, Ganesh S.
|
|
2016
|
34 |
11 |
p. 520
|
artikel
|
| 7 |
Commentary on “RNA biomarkers associated with metastatic progression in prostate cancer: A multi-institutional high-throughput analysis of SChLAP1.” Prensner JR, Zhao S, Erho N, Schipper M, Iyer MK, Dhanasekaran SM, Magi-Galluzzi C, Mehra R, Sahu A, Siddiqui J, Davicioni E, Den RB, Dicker AP, Karnes RJ, Wei JT, Klein EA, Jenkins RB, Chinnaiyan AM, Feng FY, University of Washington—Urology, Seattle, WA. Lancet Oncol 2014; 15(13):1469-80.
|
Lin, Daniel
|
|
2016
|
34 |
11 |
p. 521-522
|
artikel
|
| 8 |
Commentary on “The evolutionary history of lethal metastatic prostate cancer.” Gundem G, Van Loo P, Kremeyer B, Alexandrov LB, Tubio JM, Papaemmanuil E, Brewer DS, Kallio HM, Högnäs G, Annala M, Kivinummi K, Goody V, Latimer C, O’Meara S, Dawson KJ, Isaacs W, Emmert-Buck MR, Nykter M, Foster C, Kote-Jarai Z, Easton D, Whitaker HC, ICGC Prostate UK Group, Neal DE, Cooper CS, Eeles RA, Visakorpi T, Campbell PJ, McDermott U, Wedge DC, Bova GS, University of Washington—Urology, Seattle, WA. Nature 2015; 520(7547):353-7.
|
Lin, Daniel
|
|
2016
|
34 |
11 |
p. 520-521
|
artikel
|
| 9 |
Commentary on “The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer.” Chakravarty D, Sboner A, Nair SS, Giannopoulou E, Li R, Hennig S, Mosquera JM, Pauwels J, Park K, Kossai M, MacDonald TY, Fontugne J, Erho N, Vergara IA, Ghadessi M, Davicioni E, Jenkins RB, Palanisamy N, Chen Z, Nakagawa S, Hirose T, Bander NH, Beltran H, Fox AH, Elemento O, Rubin MA, University of Washington—Urology, Seattle, WA. Nat Commun 2014; 5:5383.
|
Lin, Daniel
|
|
2016
|
34 |
11 |
p. 522
|
artikel
|
| 10 |
Commentary on “Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer.” Hong MK, Macintyre G, Wedge DC, Van Loo P, Patel K, Lunke S, Alexandrov LB, Sloggett C, Cmero M, Marass F, Tsui D, Mangiola S, Lonie A, Naeem H, Sapre N, Phal PM, Kurganovs N, Chin X, Kerger M, Warren AY, Neal D, Gnanapragasam V, Rosenfeld N, Pedersen JS, Ryan A, Haviv I, Costello AJ, Corcoran NM, Hovens CM, University of Washington—Urology, Seattle, WA. Nat Commun 2015; 6:6605.
|
Lin, Daniel
|
|
2016
|
34 |
11 |
p. 521
|
artikel
|
| 11 |
Disease progression and kidney function after partial vs. radical nephrectomy for T1 renal cancer
|
Forbes, Connor M.
|
|
2016
|
34 |
11 |
p. 486.e17-486.e23
|
artikel
|
| 12 |
Editorial Board
|
|
|
2016
|
34 |
11 |
p. i
|
artikel
|
| 13 |
Effect of delayed resection after initial surveillance and tumor growth rate on final surgical pathology in patients with small renal masses (SRMs)
|
Hawken, Scott R.
|
|
2016
|
34 |
11 |
p. 486.e9-486.e15
|
artikel
|
| 14 |
Hepatoma-derived growth factor: A survival-related protein in prostate oncogenesis and a potential target for vitamin K2
|
Shetty, Aditya
|
|
2016
|
34 |
11 |
p. 483.e1-483.e8
|
artikel
|
| 15 |
Krüppel-like factor 4 is a novel prognostic predictor for urothelial carcinoma of bladder and it regulates TWIST1-mediated epithelial-mesenchymal transition
|
Tseng, Wei-Cheng
|
|
2016
|
34 |
11 |
p. 485.e15-485.e24
|
artikel
|
| 16 |
Localizing sites of disease in patients with rising serum prostate-specific antigen up to 1ng/ml following prostatectomy: How much information can conventional imaging provide?
|
Vargas, Hebert Alberto
|
|
2016
|
34 |
11 |
p. 482.e5-482.e10
|
artikel
|
| 17 |
Malignant ureteroenteric anastomotic stricture following radical cystectomy with urinary diversion: Patterns, risk factors, and outcomes
|
Westerman, Mary E.
|
|
2016
|
34 |
11 |
p. 485.e1-485.e6
|
artikel
|
| 18 |
Masthead
|
|
|
2016
|
34 |
11 |
p. IFC
|
artikel
|
| 19 |
Metastatic clear cell renal cell carcinoma: Circulating biomarkers to guide antiangiogenic and immune therapies
|
Zhang, Tian
|
|
2016
|
34 |
11 |
p. 510-518
|
artikel
|
| 20 |
Microfluidic enrichment of circulating tumor cells in patients with clinically localized prostate cancer
|
Todenhöfer, Tilman
|
|
2016
|
34 |
11 |
p. 483.e9-483.e16
|
artikel
|
| 21 |
New Gleason grading system: Statement from the editors of 6 journals
|
Egevad, Lars
|
|
2016
|
34 |
11 |
p. 479-480
|
artikel
|
| 22 |
Predictive medicine: Using circulating biomarkers to guide management of patients with genitourinary cancers
|
Armstrong, Andrew J.
|
|
2016
|
34 |
11 |
p. 488-489
|
artikel
|
| 23 |
Prognostic significance of markers of systemic inflammatory response in patients with non–muscle-invasive bladder cancer
|
Mbeutcha, Aurélie
|
|
2016
|
34 |
11 |
p. 483.e17-483.e24
|
artikel
|
| 24 |
Prostate cancer survivors with a passive role preference in treatment decision-making are less satisfied with information received: Results from the PROFILES registry
|
Cuypers, Maarten
|
|
2016
|
34 |
11 |
p. 482.e11-482.e18
|
artikel
|
| 25 |
Reply to letter to editor about new Gleason grading system: Statement from the editors of six journals
|
|
|
2016
|
34 |
11 |
p. 481
|
artikel
|
| 26 |
Statin use and kidney cancer outcomes: A propensity score analysis
|
Nayan, Madhur
|
|
2016
|
34 |
11 |
p. 487.e1-487.e6
|
artikel
|
| 27 |
Table of Contents
|
|
|
2016
|
34 |
11 |
p. ii-iv
|
artikel
|
| 28 |
The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non–muscle-invasive bladder cancer
|
Witjes, J. Alfred
|
|
2016
|
34 |
11 |
p. 484.e19-484.e25
|
artikel
|
| 29 |
The natural history of renal function after surgical management of renal cell carcinoma: Results from the Canadian Kidney Cancer Information System
|
Mason, Ross
|
|
2016
|
34 |
11 |
p. 486.e1-486.e7
|
artikel
|
| 30 |
The prognostic role of preoperative serum albumin/globulin ratio in patients with bladder urothelial carcinoma undergoing radical cystectomy
|
Liu, Jianye
|
|
2016
|
34 |
11 |
p. 484.e1-484.e8
|
artikel
|
| 31 |
The testosterone conundrum: The putative relationship between testosterone levels and prostate cancer
|
Loughlin, Kevin R.
|
|
2016
|
34 |
11 |
p. 482.e1-482.e4
|
artikel
|
| 32 |
Ulceration in bladder cancer associates with extravesical disease, independent of cell cycle, or hypoxia pathways status
|
Schultz, Luciana
|
|
2016
|
34 |
11 |
p. 484.e9-484.e17
|
artikel
|
| 33 |
Utilization of retroperitoneal lymph node dissection for testicular cancer in the United States: Results from the National Cancer Database (1998–2011)
|
Hugen, Cory M.
|
|
2016
|
34 |
11 |
p. 487.e7-487.e11
|
artikel
|
|
Tijdschrift beschrijving